riluzole (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the riluzole drug offered from Glenmark Pharmaceuticals Inc., USA. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
NON-PROPRIETARY NAME: | riluzole |
SUBSTANCE NAME: | RILUZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-06-18 |
END MARKETING DATE: | 0000-00-00 |
riluzole HUMAN PRESCRIPTION DRUG Details:
Item Description | riluzole from Glenmark Pharmaceuticals Inc., USA |
LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2013-06-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68462-381_f7d0144c-723e-4749-a78c-c7dd2aa41549 |
PRODUCT NDC: | 68462-381 |
APPLICATION NUMBER: | ANDA091394 |
Other RILUZOLE Pharmaceutical Manufacturers / Labelers: